Phosphoproteomic study of biological samples from patients with idiopathic macular epiretinal membrane

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033474

Enrollment

Unknown

Registered

2020-06-02

Start date

2020-06-10

Completion date

Unknown

Last updated

2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Macular Epiretinal Membrane

Interventions

idiopathic epiretinal membrane group:Nil

idiopathic macular hole group:Nil

Eligibility

Sex/Gender

All

Age

20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Both men and women, aged 20-90 years, agreed to participate in the study and signed the informed consent; 2.The patients with idiopathic macular membrane or idiopathic macular hole were diagnosed by OCT (Optical Coherence Tomography) and needed surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with previous endophthalmitis; 2. Patients with a history of vitreoretinal surgery; 3. Patients with previous intraocular injection; 4. Patients with glaucoma, retinal vein occlusion, age-related macular degeneration and other fundus diseases; 5. Patients with idiopathic macular hole who have anterior macular membrane; 6. Diabetic patients.

Design outcomes

Primary

Measure	Time frame
proteomics;	—

Countries

China

Contacts

Public ContactRongdi Yuan

The Second Affiliated Hospital of Army Medical University

1253450264@qq.com+86 13228687341

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026